Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.09

(-3.47%)

FLWS

$4.25

(-3.85%)

ACCO

$3.94

(1.41%)

ARLP

$25.32

(-0.86%)

AUIAF

$0.14

(0%)

AZZ

$140.03

(1.86%)

BTBT

$1.73

(-3.09%)

BTM

$0.49

(0%)

CVKD

$4.05

(-3.8%)

LCE:CA

$0.28

(-5%)

COCP

(-0.5%)

CDRO

$9.7

(0.94%)

CVGI

$4.96

(-2.43%)

LODE

$3.85

(-3.51%)

CMTL

$4.08

(-9.23%)

CNDT

$1.39

(-3.82%)

CXW

$25.07

(1.42%)

CMLS

$0.01

(0%)

DRCT

$2.81

(-5.07%)

DLHC

$5.59

(1.91%)

SSP

$3.35

(-1.61%)

ELDN

$3.46

(-3.35%)

EVC

$8.89

(-2.2%)

EDRY

$21.88

(0.32%)

ESEA

$66.84

(1.1%)

FAT

$0.16

(0%)

RAIL

$8.07

(1.25%)

GDEV

$12.51

(-3.96%)

GOVX

$1.25

(-6.9%)

GOCO

$0.32

(-15.2%)

GHM

$95.35

(0.01%)

GLDD

$17

(0%)

GYRE

$7.58

(-1.88%)

HMENF

(-1.58%)

III

$4.13

(-2.82%)

IPOOF

$12.01

(-2.96%)

KELYA

$11.65

(-1.94%)

KTOS

$54.58

(-5.46%)

LUCK

$7.46

(-8.58%)

MAIA

$1.28

(0.79%)

MGROF

$0.35

(0%)

NTRB

$3.5

(-0.85%)

OCGN

$1.25

(-1.19%)

PERF

$1.69

(1.2%)

QMCI

$0.16

(0%)

RGP

$4.63

(2.1%)

SGA

$8.91

(-0.67%)

SHWZ

(0%)

SHIP

$15.4

(-0.03%)

SLQT

$0.85

(0.85%)

SKYX

(-5.08%)

SNAL

$0.75

(-1.06%)

GEO

$26.67

(-0.04%)

ODP

$28

(0%)

TNXP

$11.2

(-4.36%)

TSQ

$6.39

(-2.59%)

TZOO

$10.06

(-0.45%)

UNCY

$7.06

(6.01%)

VVX

$83.86

(-0.99%)

VNCE

$4.39

(-6%)

XELB

$1.87

(-1.58%)

ZOMDF

$0.09

(-3.47%)

FLWS

$4.25

(-3.85%)

channelchek-in

‌

6/9/2026

Novanta Pays Up to $1.45 Billion for Riverpoint Medical as the Minimally Invasive Surgery Market Heats Up

Novanta Inc. (Nasdaq: NOVT), a Boston-based technology partner to medical and industrial original equipment manufacturers, announced Tuesday it has entered into a definitive agreement to acquire Riverpoint Medical from private equity firm Arlington Capital Partners in a deal valued at up to $1.45 billion. The transaction includes $1.2 billion in upfront cash consideration at closing, expected in the third quarter of 2026, and a $250 million milestone payment scheduled for the first quarter of 2027, subject to customary regulatory approvals and closing conditions.

3 min read